A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, Study Finds
Posted inAlzheimer's Disease Blood Brain Clinical Trials Computerized Axial Tomography (CAT Scans) Dementia Doctors JAMA (Journal of American Medical Assn) Memory Research Tests (Medical) your-feed-healthcare your-feed-science

A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, Study Finds

It was much more accurate than primary care doctors using cognitive tests and CT scans. The findings could speed the quest for an affordable and accessible way to diagnose patients with memory problems.
Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug
Posted inAcademic and Scientific Journals Alzheimer's Disease Appointments and Executive Changes Cassava Sciences Inc City College of New York Clinical Trials Drugs (Pharmaceuticals) Falsification of Data Research Securities and Commodities Violations your-feed-science

Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug

The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a research collaborator.
New Drug Approved for Early Alzheimer’s
Posted inAlzheimer's Disease Biogen Inc Brain Clinical Trials Dementia Drugs (Pharmaceuticals) Eisai Co Ltd Eli Lilly and Company Food and Drug Administration Leqembi (Drug) Memory Placebos Prices (Fares, Fees and Rates) your-feed-healthcare your-feed-science

New Drug Approved for Early Alzheimer’s

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.